Monday, October 05, 2026

The Tasty Stew That Helps Dr. Jonathan Rasouli Maintain His Memory

Most of us encounter the word "dementia" somewhere between our 30s and 40s. At first, we worry about our parents and older relatives, and only then do we slowly begin to truly understand how important it is to protect our brain. This is crucial to preserving our memories, our ability to think clearly, and our connection to the world over time. The good news is that recent studies show that what we eat may directly impact the risk of cognitive decline in old age and even delay the development of diseases like Alzheimer’s and dementia in general. This is where Dr. Jonathan Rasouli comes in—a neurosurgeon who isn’t afraid to step into the kitchen and cook with a medical book in one hand and a wooden spoon in the other. Dr. Rasouli has a dish he prepares for himself every week that might look like just another homemade stew with vegetables and lentils, but there’s a good chance it’s the smartest meal you’ll put in your pot and stomach soon.

Dementia and Alzheimer’s - What Do We Know and What Can We Do to Protect Ourselves? 

It’s important to note that while these are two terms we hear more and more about as the years go by, they don’t describe exactly the same thing. "Dementia" is a general term that describes a decline in cognitive function: memory problems, difficulty with orientation, poor judgment, and changes in behavior or language. It’s not a single disease but a medical condition that can stem from various causes. Alzheimer’s, on the other hand, is the most common cause of dementia because it’s a neurodegenerative disease that progressively and irreversibly damages the brain. All Alzheimer’s is dementia, but not all dementia is Alzheimer’s. 

In other types of dementia, such as vascular dementia (caused by strokes or impaired blood flow to the brain), it’s sometimes possible to prevent further deterioration by carefully managing blood pressure, diabetes, and cholesterol levels. It’s also important not to neglect the mental and social aspects—people who continue to challenge themselves mentally (e.g., through reading, learning, solving crosswords, etc.), maintain social connections, and participate in activities often retain higher cognitive function over time. 

In the case of Alzheimer’s, the damage begins in the brain areas responsible for memory and gradually spreads to other functions. The exact causes of the disease are still not fully clear, but there is evidence linking Alzheimer’s to genetic, inflammatory, and environmental factors. To reduce the risk of developing the disease, it’s recommended to maintain a healthy diet (such as the Mediterranean diet or the MIND diet), engage in regular physical activity, protect heart and vascular health, avoid smoking, and ensure adequate sleep. The earlier you start, the better your chances of delaying the process, and now we’ll show you a tasty and simple way to do so.

From the Operating Room to the Kitchen: Dr. Rasouli’s Recipe

Dr. Jonathan Rasouli is not exactly what people imagine when they think of a surgeon. He is indeed a senior spine neurosurgeon at Northwell Health in New York, but the wisdom he applies in the operating room isn’t reserved solely for scientific papers—he cooks with it. In recent years, Dr. Rasouli has been explaining to others how much impact diet has on memory and how delicious and healthy it is to use it to protect the brain. Rasouli believes that diet is not only a therapeutic tool but also a means of prevention—especially when it comes to brain health. According to him, there are plenty of things we can’t control when it comes to dementia or Alzheimer’s, but there are also things we can, and the food we eat is one of them. After years of medical research and plenty of kitchen experiments, he developed a simple recipe that he eats every week. A warm lentil stew with spinach, garlic, and turmeric—easy to prepare, nutritious, delicious, and above all, brain-boosting.

Dr. Rasouli’s Recipe – A Heartwarming, Brain-Boosting Lentil Stew

Dr. Rasouli didn’t reinvent the wheel. His stew is based on the principles of the Mediterranean diet and the MIND diet mentioned earlier. Studies have shown that adhering to a menu tailored to these methods may reduce the risk of Alzheimer’s by up to 53%. “It’s not magic—it’s simply understanding what your body needs and giving it that regularly,” says the doctor. “I make the following dish at the end of the week, and it lasts almost the entire week,” he shares. “It’s convenient, healthy, and gives me peace of mind—both in body and mind.” 

Ingredients:  

1 cup dried red lentils (a source of fiber and plant-based protein) 

1 small onion, chopped (a source of B vitamins, vitamin C, and minerals) 

2 cloves garlic, minced 

2 cups chopped spinach (a source of folic acid and vitamin K) 

1 tbsp extra virgin olive oil (a source of omega-9 and polyphenols) 

1 tsp turmeric (a powerful antioxidant) 

1 tsp coriander (optional) 

 3 cups vegetable broth 

 Salt, black pepper, and cumin to taste

Preparation:
 

1. Heat the oil in a medium-large pot, add the onion, and sauté until translucent. 

2. Add the garlic and spices—sauté for a minute until the pot releases a fragrant aroma. 

3. Add the lentils and broth or water with vegetable stock powder, bring to a boil, and simmer for 20 minutes. 

4. Add the spinach and cook for an additional 5–7 minutes. 

5. Serve hot—as a light dish or a full meal alongside quinoa or brown rice.

In Summary 

 If there’s one thing we’ve learned from Dr. Rasouli, it’s that you don’t need a medical degree to start protecting your brain—just good intentions and one simple pot. This dish won’t permanently or completely protect your brain from dementia or Alzheimer’s, but it reminds us that big changes start with small steps: the right seasoning, smart dietary choices, and care for our health. So, before you head out shopping next time, it might be worth adding some spinach, lentils, and turmeric to your cart and cooking for yourself and your loved ones something that could become a small, nourishing tradition for good memory, in body and soul.

This is only for your information, kindly take the advice of your doctor for food, medicines, exercises and so on.   


Labels: , , , , , , , , , , ,

New Treatments for Ulcerative Colitis

Ulcerative colitis (UC), a chronic inflammatory bowel disease, continues to be the subject of extensive scientific research as medical professionals seek better ways to manage this challenging condition. Recent developments include FDA approval of new medications, with researchers actively studying additional treatments in clinical trials.

The primary goal of UC treatment is to stop the immune system from attacking the intestinal lining, thereby reducing inflammation, alleviating symptoms, and achieving remission. Doctors now have an expanding arsenal of medications to help patients reach these objectives.

Current Treatment Options 

Treatment selection depends on several factors: disease severity (mild, moderate, or severe), previously tried medications, response to those treatments, and overall health status.

Aminosalicylates (5-ASA Drugs) 

Aminosalicylates represent the first-line treatment for UC, containing the active ingredient 5-aminosalicylic acid (5-ASA). This category includes mesalamine (Apriso, Asacol HD, Canasa, Pentasa), olsalazine (Dipentum), balsalazide (Colazal), and sulfasalazine (Azulfidine). 

These medications, taken orally or as enemas, reduce intestinal inflammation and work best for mild to moderate UC. They have demonstrated effectiveness in both inducing and maintaining remission. 

The American Gastroenterological Association (AGA) strongly recommends that adults with mild to moderate UC choose a standard dose of oral mesalamine, olsalazine, or balsalazide over low-dose mesalamine, sulfasalazine, or no treatment. A standard mesalamine dose is 2 to 3 grams daily. 

Recent research examining UC prevalence in the Middle East called 5-ASA "the gold standard for the induction of remission in patients with mild to moderate UC according to multiple international guidelines," reinforcing the AGA's recommendation.

Corticosteroids 

Corticosteroids suppress the immune system to reduce inflammation and are typically used for patients hospitalized with acute severe UC. Examples include prednisone (Prednisone Intensol, Rayos), prednisolone (Prelone, Millipred), methylprednisolone (Medrol), and budesonide (Uceris). 

Doctors may also prescribe these medications short-term to manage symptom flares. Administration methods include oral tablets, injections, intravenous infusion, and rectal foam. 

However, long-term steroid use isn't advisable due to potential side effects including high blood sugar, weight gain, infections, and bone loss. Patients should discuss these risks and treatment timelines with their healthcare providers. 

Immunomodulators 

Immunomodulators suppress the immune system to prevent inflammation and are typically combined with biologics to treat severe UC. Doctors may prescribe these medications when symptoms don't respond to aminosalicylates.

Examples include azathioprine (Azasan, Imuran), mercaptopurine (Purixan), and methotrexate (Otrexup, Trexall, Rasuvo). Methotrexate can increase the risk of stomach and intestinal problems, and a 2018 study suggested it may not effectively help people with UC maintain remission. 

In 2020, an AGA expert panel recommended using immunomodulators in combination with biologics for moderate to severe UC when aminosalicylates haven't worked. While the FDA hasn't approved immunomodulators specifically for UC treatment, doctors may still prescribe them off-label.

Biologics 

Biologics are manufactured from genetically engineered proteins or other natural substances that target specific immune system components driving inflammation. 

A 2023 research review examined five licensed biologics: 

 Adalimumab: Effective in both short and long-term treatment  

Infliximab: Induces short-term response, remission, and mucosal healing 

Golimumab: Similar to other biologics but requires more dose monitoring 

Vedolizumab: Shows higher remission rates than adalimumab and costs less

Ustekinumab: The newest drug improves remission rates but requires more research 

TNF Blockers 

Anti-TNF drugs block tumor necrosis factor (TNF), an immune system protein that triggers inflammation. These medications help people with moderate to severe UC whose symptoms haven't improved with other treatments. 

TNF blockers include adalimumab (Humira), golimumab (Simponi), and infliximab (Remicade). Adalimumab and golimumab are administered via subcutaneous injection, while infliximab is given through IV infusion. 

Vedolizumab (Entyvio) 

Vedolizumab treats moderate to severe disease by preventing damaging white blood cells from entering the gastrointestinal tract and causing inflammation. Previously available only through IV infusion, the FDA recently approved subcutaneous administration. 

Choosing a Biologic 

The AGA suggests that people with moderate to severe UC who are new to biologics choose infliximab or vedolizumab rather than adalimumab, as the former options are more effective. 

However, some patients may find adalimumab more convenient since it can be self-administered, while other biologics require healthcare professional administration. Adalimumab is a reasonable choice if you prefer self-injectable medication or find it more accessible or affordable. Patients should discuss all options with their doctors.

Surgery 

When medications fail to control symptoms or complications arise, surgery may become necessary. This typically involves removing the affected portion of the colon.

The Takeaway 

Beyond currently available medications, researchers continue investigating new and potentially improved treatments through clinical trials. In 2023, the FDA approved a new medication for treating moderate to severe UC in adults, expanding the therapeutic options available to patients. 

The landscape of UC treatment continues to evolve, with an increasing number of effective medications and ongoing research promising additional options. Working closely with healthcare providers to find the right treatment combination—considering disease severity, previous treatments, and individual circumstances—remains key to successfully managing ulcerative colitis and achieving lasting remission.


This is only for your information, kindly take the advice of your doctor for food, medicines, exercises and so on.   


Labels: , , ,